The Hindu Business Line : United Biotech ties up with Italian co

Kedrion, which specialises in the development, production and distribution of plasmaderivatives , has licensed its Human Albumin, Intravenous Immunoglobulin, Hepatitis Immunoglobulin and Anti-D Immunoglobulin products to the New Delhi based company.

Blood plasma products are used in the treatment of hemophilic patients, patients with immune system deficiencies, for pregnancy-related complications, in the treatment of malnutrition, malaria and severe life-threatening anemia amongst children as well as for trauma victims. According to the company, Kedrion products would fill the critical and growing void in this segment.

"This agreement represents a major validation of our commercial potential and also marks a successful achievement of our company's objective to in-license through strategic partnerships," said Mr R.K. Dewan, Vice-President, Marketing, United Biotech.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Tata Tea makes $523-m profit with Glaceau sale

Suzlon acquires REpower for € 1.35-b as Areva backs out

`REpower takeover won't affect Suzlon'

What next for Suzlon?

Suzlon: Winds blow in favour

For Tulsi Tanti, it's 17th time lucky

ETA Star ties up with TN for township project

Indian oil cos will have to bid anew for Iraqi blocks

United Biotech ties up with Italian co

NTPC inks energy pact with Nigeria

Manjushree Extrusions plans to expand capacity

Paradip-Haldia crude pipeline to be ready soon

Ramky group turnover touches Rs 1,000 cr